Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer;Diagnose, therapie und nachsorge des differenzierten schilddrü senkarzinoms

Wiener Medizinische Wochenschrift

Volumn 155, Issue 19-20, 2005, Pages 429-435

  Lind, Peter ^a   Igerc, Isabel ^a   Kohlfürst, Susanne ^a  

^a GENERAL HOSPITAL KLAGENFURT   (Austria)

Author keywords

Diagnostic modalities; FDG PET CT; Follow up methods; Recombinant TSH; Thyroglobulin; Thyroid cancer; Treatment; Ultrasonography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE 131; LEVOTHYROXINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PERTECHNETIC ACID TC 99M; RADIOACTIVE IODINE; RECOMBINANT THYROTROPIN; TETROFOSMIN TC 99M; THYROGLOBULIN; THYROID HORMONE; THYROTROPIN;

CANCER DIAGNOSIS; CANCER RADIOTHERAPY; EARLY DIAGNOSIS; ECHOGRAPHY; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; NECK DISSECTION; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE FRACTIONATION; REVIEW; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; THYROID PAPILLARY CARCINOMA; THYROID SCINTISCANNING; THYROIDECTOMY; TUMOR BIOPSY; WHOLE BODY SCINTISCANNING;

BIOPSY, FINE-NEEDLE; CARCINOMA; COMBINED MODALITY THERAPY; DIAGNOSTIC IMAGING; HUMANS; IODINE RADIOISOTOPES; LYMPH NODES; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; THYROID FUNCTION TESTS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 28044459859     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-005-0219-8     Document Type: Review

References (25)

1. Lind P, Molnar M, Langsteger W, Gomez I (1998) Epidemiology of thyroid diseases in iodine sufficiency. Thyroid 8: 1179-1183
2. Gomez-Segovia I, Gallowitsch HJ, Kresnik E, Kumnig G, Igerc I, Matschnig S, Stronegger WJ, Lind P (2004) Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984-2001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: population based age stratefied analysis on thyroid carcinoma incidence. Thyroid 14: 277-286
3. Mikosch P, Gallowitsch HJ, Kresnik E, Lind P (2000) Präoperative Dignitätsabklärung von Schilddrüsenknoten im Strumaendemiegebiet: Möglichkeiten und Limitationen. Wien Med Wochenschr 150: 278-287
4. Antonelli A, Miccoli P, Ferdeghini M, Di Coscio G, Alberti B, Iacconi P, Baldi V, Falloni P, Baschieri L (1995) Role of neck ultrasonography in the follow up of patients operated on for thyroid cancer. Thyroid 5: 25-28
5. Gharib H, Goellner JR, Johnson DA (1993) Fine needle aspiration cytology of the thyroid: a 12 year experience with 11,000 biopsies. Clin Lab Med 13: 699-709
6. Mikosch P, Gallowitsch HJ, Kresnik E, Jester J, Würtz FG, Kerschbaumer K, Unterweger O, Dinges HP, Lind P (2000) Value of ultrasound-guided fine needle aspiration biopsy of thyroid nodules in an endemic goitre area. Eur J Nucl Med 27: 62-69
7. Mikosch P, Wartner U, Kresnik E, Gallowitsch HJ, Heinisch M, Dinges HP, Lind P (2001) Results of preoperative ultrasound guided fine needle aspiration biopsy of solitary nodules as compared with histology: A retrospective analysis of 538 patients. Nuklearmedizin 40: 148-154
8. Lind P (1999) Multi-tracer imaging of thyroid nodules: is there a role in the preoperative assessment of nodular goiter? Eur J Nucl Med 26: 795-797
9. Kresnik E, Gallowitsch HJ, Mikosch P, Stettner H, Igerc I, Gomez I, Kumnig G, Lind P (2003) Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery 133: 294-299
10. Kresnik E, Gallowitsch HJ, Mikosch P, Unterweger O, Gomez I, Lind P (2000) Scinigraphic and ultrasonographic appearance in different tumor stages of thyroid carcinoma. Acta Med Austriaca 27: 32-35
11. Kresnik E, Gallowitsch HJ, Mikosch P, Gomez I, Lind P (1997) Tc-99m MIB1 scintigraphy of thyroid nodules in an endemic goiter area. J Nucl Med 38: 62-65
12. Kresnik E, Gallowitsch HJ, Mikosch P, Molnar M, Pipam W, Gomez I, Lind P (1997) Evaluation of thyroid nodules with Tc-99m tetrofosmin dual phase scintigraphy. Eur J Nucl Med 24: 716-721
13. Lind P, Igerc I (2006) Radioiodine therapy - malignant disease. In: Biersack HJ, Freeman LM (eds) Nuclear Medicine Concise. Springer, Heidelberg New York, in press
14. Lubin E, Mechlis-Frish S, Zatz S, Shimani A, Segal K, Avraham A, Levy R, Feinmesser R (1994) Serum thyroglobulin and I-131 whole body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma. J Nucl Med 35: 257-262
15. Schlumberger M, Berg G, Cohen O, Duntas L, Jamar F, Jazareb B, Limbert E, Lind P, Pacini F, Reiners C, Sanchez-Franco F, Toft A, Wiersinga WM (2004) Follow-up of low risk patients with differentiated thyroid carcinoma: a European perspective. Eur J Endocrinol 150: 105-112
16. Lind P (1999) I-131 whole body scintigraphy in thyroid cancer patients. Q J Nucl Med 43: 188-194
17. Kohlfürst S, Igerc I, Lind P (2005) Recombinant human thyrotropin is helpful in the follow-up and I-131 therapy with thyroid cancer: report of the results and benefits of using recombinant human thyrotropin in clinical routine. Thyroid 15: 371-376
18. Lind P, Gallowitsch HJ, Langsteger W, Kresnik E, Mikosch P, Gomez I (1997) Technetium-99m Tetrofosmin whole body scintigraphy in the follow-up of differentiated thyroid carcinoma. J Nucl Med 38: 348-352
19. Feine U, Lizenmayer R, Hanke JP, Held J, Wohrle H, Muller-Schauenburg W (1996) Fluorine-18 FDG and iodine-131 uptake in thyroid cancer. J Nucl Med 37: 1468-1472
20. Grünwald F, Menzel C, Bender H, Palmedo H, Willkomm P, Ruhlmann J, Franckson T, Biersack HJ (1997) Comparison of 18FDG-PET with 131-iodine and 99m Tc-sestamibi scintigraphy in differentiated thyroid cancer. Thyroid 7: 327-335
21. Dietlein M, Scheidhauer K, Voth E, Theissen P, Schicha H (1997) FDG PET and iodine-131 whole body scintigraphy in the follow up of differentiated thyroid cancer. Eur J Nucl Med 24: 1342-1348
22. Reske SN, Kotzerke J (2001) FDG PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference 2000. Eur J Nucl Med 28: 1707-1723
23. Kumnig G (2002) Stellenwert der FDG PET beim Schilddrüsenkarzinom. Wien Med Wochenschr 152: 280-285
24. Petrich T, Börner AR, Weckesser E, Soudah B, Otto D, Widjajaa, Hofmann M, Kreipe HH, Knapp WH (2001) Follow-up of thyroid cancer patients using rhTSH-preliminary results. Nucl Med 40: 7-14
25. Lind P, Igerc I (2004) PET and PET/CT in the following up of thyroid cancer patients. In: Langsteger W, Sungler P, Lind P, Niederle B (eds) (2004) Thyroid cancer four. KOOP Vienna CD Rom